• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, March 8, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Tumor-killing liquid offers a safer “bridge” therapy for patients with liver cancer

Bioengineer by Bioengineer
February 10, 2021
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: [Credit: H. Albadawi et al., Science Translational Medicine (2021)]

A liquid formulation can kill swathes of liver cancer cells and potentiate chemotherapy treatments, according to a study conducted in mice, rabbits, pigs and human tumor samples. The liquid could offer clinicians a safer and cheaper “bridge” to keep tumors in check in patients waiting for life-saving liver transplants. Chemotherapy remains the treatment of choice for patients with hepatocellular carcinoma (HCC), but these drugs have not made a major impact on five-year patient survival rates, which remain dismally low at around 9%. However, research has shown that liver transplantation can drastically improve outcomes in patients, raising 5-year survival rates to approximately 80%. Securing a liver transplant is therefore a major priority for clinicians and patients with early-stage disease, but organs are often difficult to find. In the meantime, clinicians keep tumors in check with local techniques such as thermal ablation – a procedure that vaporizes cancer cells with heat – but these approaches are resource-intensive, cannot be applied to all tumors, and can damage surrounding tissues. Hassan Albadawi and colleagues designed an alternative ablation technique based on an ionic liquid named LATTE, which can deliver both ablating agents and chemotherapy drugs directly into tumors. The team found that injections of LATTE shrank tumors either alone or in combination with the chemotherapy drug doxorubicin in rat and rabbit models of HCC, and rapidly killed cancer cells in 12 resected human tumors. “We anticipate that the safety profile of LATTE, its low cost, its simplicity of use, and the flexibility to repeat the procedure will make this [technique] appealing to physicians,” the authors say.

###

Media Contact

Related Journal Article

http://dx.doi.org/10.1126/scitranslmed.abe3889

Tags: cancerMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Oncotarget: High-fat ovariectomized mice susceptible to accelerated tumor growth

March 8, 2021
IMAGE

Oncotarget: Estrogen receptor α polymorphism is associated with dementia

March 8, 2021

Oncotarget: Sensitivity testing on ovarian cancer cells isolated from malignant ascites

March 8, 2021

The amazing promise of artificial intelligence in health care

March 8, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    702 shares
    Share 281 Tweet 176
  • People living with HIV face premature heart disease and barriers to care

    86 shares
    Share 34 Tweet 22
  • Global analysis suggests COVID-19 is seasonal

    39 shares
    Share 16 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

cancerCell BiologyEcology/EnvironmentTechnology/Engineering/Computer ScienceBiologyMedicine/HealthChemistry/Physics/Materials SciencesClimate ChangeMaterialsGeneticsInfectious/Emerging DiseasesPublic Health

Recent Posts

  • Canadian innovators use video games to help children with neurodevelopment disabilities
  • Speeding treatment for urinary tract infections in children
  • New technique brings the study of molecular configuration into the microscopic domain
  • Rise of marine predators reshaped ocean life as dramatically as sudden mass extinctions
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In